PROCEDURE  ||| S:0 E:10 ||| NN
AND  ||| S:10 E:14 ||| CC
FEASIBILITY  ||| S:14 E:26 ||| NNP
OF  ||| S:26 E:29 ||| IN
LAPAROSCOPIC  ||| S:29 E:42 ||| NNP
RENAL  ||| S:42 E:48 ||| NNP
BIOPSY  ||| S:48 E:55 ||| NNP
Recently ||| S:55 E:63 ||| NNP
,  ||| S:63 E:65 ||| ,
laparoscopic  ||| S:65 E:78 ||| JJ
surgery  ||| S:78 E:86 ||| NN
is  ||| S:86 E:89 ||| VBZ
the  ||| S:89 E:93 ||| DT
standard  ||| S:93 E:102 ||| JJ
procedure  ||| S:102 E:112 ||| NN
in  ||| S:112 E:115 ||| IN
urological  ||| S:115 E:126 ||| JJ
field ||| S:126 E:131 ||| NN
.  ||| S:131 E:133 ||| .
We  ||| S:133 E:136 ||| PRP
report  ||| S:136 E:143 ||| VBP
the  ||| S:143 E:147 ||| DT
experience  ||| S:147 E:158 ||| NN
of  ||| S:158 E:161 ||| IN
laparoscopic  ||| S:161 E:174 ||| JJ
renal  ||| S:174 E:180 ||| JJ
biopsy  ||| S:180 E:187 ||| NN
for  ||| S:187 E:191 ||| IN
4  ||| S:191 E:193 ||| CD
patients  ||| S:193 E:202 ||| NNS
who  ||| S:202 E:206 ||| WP
have  ||| S:206 E:211 ||| VBP
contraindication  ||| S:211 E:228 ||| VBN
of  ||| S:228 E:231 ||| IN
ultrasound-guided  ||| S:231 E:249 ||| JJ
percutaneous  ||| S:249 E:262 ||| JJ
renal  ||| S:262 E:268 ||| JJ
biopsy ||| S:268 E:274 ||| NN
.  ||| S:274 E:276 ||| .
We  ||| S:276 E:279 ||| PRP
retrospectively  ||| S:279 E:295 ||| VBP
reviewed  ||| S:295 E:304 ||| VBN
the  ||| S:304 E:308 ||| DT
patients  ||| S:308 E:317 ||| NNS
who  ||| S:317 E:321 ||| WP
underwent  ||| S:321 E:331 ||| VBD
laparoscopic  ||| S:331 E:344 ||| JJ
renal  ||| S:344 E:350 ||| JJ
biopsy  ||| S:350 E:357 ||| NNS
( ||| S:357 E:358 ||| -LRB-
LRB ||| S:358 E:361 ||| NNP
)  ||| S:361 E:363 ||| -RRB-
from  ||| S:363 E:368 ||| IN
March  ||| S:368 E:374 ||| NNP
2010  ||| S:374 E:379 ||| CD
to  ||| S:379 E:382 ||| TO
June  ||| S:382 E:387 ||| NNP
2013  ||| S:387 E:392 ||| CD
in  ||| S:392 E:395 ||| IN
our  ||| S:395 E:399 ||| PRP$
hospital ||| S:399 E:407 ||| NN
.  ||| S:407 E:409 ||| .
Four  ||| S:409 E:414 ||| CD
female  ||| S:414 E:421 ||| NN
with  ||| S:421 E:426 ||| IN
mean  ||| S:426 E:431 ||| JJ
age  ||| S:431 E:435 ||| NN
of  ||| S:435 E:438 ||| IN
54.5  ||| S:438 E:443 ||| CD
years  ||| S:443 E:449 ||| NNS
old  ||| S:449 E:453 ||| JJ
underwent  ||| S:453 E:463 ||| JJ
LRB ||| S:463 E:466 ||| NNP
.  ||| S:466 E:468 ||| .
Two  ||| S:468 E:472 ||| CD
patients  ||| S:472 E:481 ||| NNS
had  ||| S:481 E:485 ||| VBD
solitary  ||| S:485 E:494 ||| JJ
kidney  ||| S:494 E:501 ||| NN
and  ||| S:501 E:505 ||| CC
the  ||| S:505 E:509 ||| DT
other  ||| S:509 E:515 ||| JJ
2  ||| S:515 E:517 ||| CD
patients  ||| S:517 E:526 ||| NNS
had  ||| S:526 E:530 ||| VBD
bleeding  ||| S:530 E:539 ||| VBG
tendency ||| S:539 E:547 ||| NN
.  ||| S:547 E:549 ||| .
All  ||| S:549 E:553 ||| PDT
the  ||| S:553 E:557 ||| DT
biopsy  ||| S:557 E:564 ||| NN
was  ||| S:564 E:568 ||| VBD
performed  ||| S:568 E:578 ||| VBN
retroperitoneal  ||| S:578 E:594 ||| JJ
approach ||| S:594 E:602 ||| NN
.  ||| S:602 E:604 ||| .
We  ||| S:604 E:607 ||| PRP
used  ||| S:607 E:612 ||| VBD
18-gauge  ||| S:612 E:621 ||| CD
biopsy  ||| S:621 E:628 ||| JJ
needle  ||| S:628 E:635 ||| NN
to  ||| S:635 E:638 ||| TO
take  ||| S:638 E:643 ||| VB
renal  ||| S:643 E:649 ||| JJ
cortical  ||| S:649 E:658 ||| JJ
tissue  ||| S:658 E:665 ||| NN
in  ||| S:665 E:668 ||| IN
all  ||| S:668 E:672 ||| DT
cases ||| S:672 E:677 ||| NNS
.  ||| S:677 E:679 ||| .
In  ||| S:679 E:682 ||| IN
addition ||| S:682 E:690 ||| NN
,  ||| S:690 E:692 ||| ,
one  ||| S:692 E:696 ||| CD
patient  ||| S:696 E:704 ||| NN
underwent  ||| S:704 E:714 ||| VBD
small  ||| S:714 E:720 ||| JJ
wedge  ||| S:720 E:726 ||| NN
biopsy  ||| S:726 E:733 ||| NN
with  ||| S:733 E:738 ||| IN
a  ||| S:738 E:740 ||| DT
cold  ||| S:740 E:745 ||| JJ
knife ||| S:745 E:750 ||| NN
.  ||| S:750 E:752 ||| .
Mean  ||| S:752 E:757 ||| VB
operative  ||| S:757 E:767 ||| JJ
time ||| S:767 E:771 ||| NN
,  ||| S:771 E:773 ||| ,
pneumoperitoneal  ||| S:773 E:790 ||| JJ
time ||| S:790 E:794 ||| NN
,  ||| S:794 E:796 ||| ,
and  ||| S:796 E:800 ||| CC
estimated  ||| S:800 E:810 ||| JJ
blood  ||| S:810 E:816 ||| NN
loss  ||| S:816 E:821 ||| NN
was  ||| S:821 E:825 ||| VBD
63.0  ||| S:825 E:830 ||| CD
min  ||| S:830 E:834 ||| NNS
( ||| S:834 E:835 ||| -LRB-
range  ||| S:835 E:841 ||| FW
48-92  ||| S:841 E:847 ||| FW
min ||| S:847 E:850 ||| FW
) ||| S:850 E:851 ||| -RRB-
,  ||| S:851 E:853 ||| ,
37.5  ||| S:853 E:858 ||| CD
min  ||| S:858 E:862 ||| NNS
( ||| S:862 E:863 ||| -LRB-
range  ||| S:863 E:869 ||| NN
22-75 ||| S:869 E:874 ||| CD
) ||| S:874 E:875 ||| -RRB-
,  ||| S:875 E:877 ||| ,
and  ||| S:877 E:881 ||| CC
11.25  ||| S:881 E:887 ||| CD
ml  ||| S:887 E:890 ||| NNS
( ||| S:890 E:891 ||| -LRB-
range  ||| S:891 E:897 ||| FW
0-30  ||| S:897 E:902 ||| FW
ml ||| S:902 E:904 ||| FW
) ||| S:904 E:905 ||| -RRB-
,  ||| S:905 E:907 ||| ,
respectively ||| S:907 E:919 ||| RB
.  ||| S:919 E:921 ||| .
No  ||| S:921 E:924 ||| DT
perioperative  ||| S:924 E:938 ||| JJ
complication  ||| S:938 E:951 ||| NN
was  ||| S:951 E:955 ||| VBD
observed ||| S:955 E:963 ||| VBN
.  ||| S:963 E:965 ||| .
In  ||| S:965 E:968 ||| IN
all  ||| S:968 E:972 ||| DT
cases ||| S:972 E:977 ||| NNS
,  ||| S:977 E:979 ||| ,
we  ||| S:979 E:982 ||| PRP
can  ||| S:982 E:986 ||| MD
diagnose  ||| S:986 E:995 ||| VB
pathologically  ||| S:995 E:1010 ||| VBN
by  ||| S:1010 E:1013 ||| IN
LRB ||| S:1013 E:1016 ||| NNP
.  ||| S:1016 E:1018 ||| .
LRB  ||| S:1018 E:1022 ||| NNP
is  ||| S:1022 E:1025 ||| VBZ
safe ||| S:1025 E:1029 ||| JJ
,  ||| S:1029 E:1031 ||| ,
effective ||| S:1031 E:1040 ||| JJ
,  ||| S:1040 E:1042 ||| ,
and  ||| S:1042 E:1046 ||| CC
feasible  ||| S:1046 E:1055 ||| JJ
procedure  ||| S:1055 E:1065 ||| NN
for  ||| S:1065 E:1069 ||| IN
the  ||| S:1069 E:1073 ||| DT
patients  ||| S:1073 E:1082 ||| NNS
in  ||| S:1082 E:1085 ||| IN
whom  ||| S:1085 E:1090 ||| WP
ultrasound-guided  ||| S:1090 E:1108 ||| JJ
percutaneous  ||| S:1108 E:1121 ||| JJ
renal  ||| S:1121 E:1127 ||| JJ
biopsy  ||| S:1127 E:1134 ||| NN
is  ||| S:1134 E:1137 ||| VBZ
contraindication ||| S:1137 E:1153 ||| VBN
.  ||| S:1153 E:1155 ||| .
